Antibiotic activity in serum from a model for type II diabetes was similar to that in normal sera or media containing cholesterol but lacking glucose, insulin, or both. The ratio of effects of broth plus obese-rat serum to effects of broth plus lean-rat serum supplemented with cholesterol approached or equaled 1.
The interactions of antibiotics with serum components, including serum proteins and cholesterol, have been demonstrated to be important determinants of their activity in serum. It has been well documented that the levels and types of proteins found in serum can profoundly affect antibiotic activity, especially that of penicillin and others of the 1-lactam class (1, 2) . Another serum component, cholesterol, which is commonly elevated in persons in Western society, can act as a competitive inhibitor for members of the polyene class of antibiotics, such as amphotericin B (6, 11) . Obesity is often associated with changes in the levels of serum components. In obesity-associated type II diabetes, both serum insulin and glucose can be elevated. Altered levels of cholesterol, triglycerides, free fatty acids, and lipoproteins are also commonly associated with obesity and type II diabetes (3, 10, 13, 14) . The effect that these skewed levels of serum components have on antibiotic activity is not known.
In this study, we investigated the influence that abnormal levels of serum components associated with type II diabetes have on the performance of antibiotics in the serum dilution test for-bactericidal activity. To accomplish this, we used serum from an animal model for type II diabetes, the obese (fa/fa) Zucker rat model (7) . This animal has many charactenrstics in common with humans with type II diabetes, including hyperglycemia, hyperinsulinemia, and hypercholesterolemia (8, 9) . Mueller-Hinton broth (MHB; lot 767498; Difco, Detroit, Mich.) was supplemented with CaCl2 (50 mg/liter) and MgSO4 (20 mg/liter) (17, 20) to give final concentrations of 1.4 mM Ca2+ and 1.0 mM Mg2+ and was used in all determinations of bacterial (MICs) and minimum lethal concentrations (MLCs). Buffered yeast-nitrogen base (Difco) with 1% glucose and 0.15% asparagine (12) (YNB) was used for all fungal susceptibility tests. Pooled serum from adult (9-month-old) lean and obese Zucker rats was used. The pooled serum was stored at -20°C until use.
Prior to use, the bacteria used were stored in 10% glycerol plus brain heart infusion broth at -70°C. romycin and ceftriaxone, were either unchanged from the MIC measured in medium alone or within a range of one-half to two times the MIC in medium alone. The addition of cholesterol to either medium alone or medium with 50% lean-rat serum yielded trends similar to that measured for medium with obese-rat serum. Overall, the ratio of the MIC in medium supplemented with obese-rat serum to the MIC in medium with either cholesterol or lean-rat serum and cholesterol approached or equaled one. The MICs in the presence of broth with 50% lean-rat serum and cholesterol for amikacin and doxycycline were unchanged for E. coli. However, the activity of these antibiotics against P. aeruginosa was slightly enhanced. The ratio for gentamicin was 2.6 for P. aeruginosa and 11.0 for E. coli. The MICs of ampicillin, ceftriaxone, and amphotericin B were significantly elevated over those in broth medium alone. A comparison of antibiotic activity in the presence of obese-rat serum with that in the presence of lean-rat serum is also provided. The MICs measured in the presence of obese-rat serum were unaltered from those for lean-rat serum for doxycycline and ketoconazole. Amphotericin B activity against C. albicans was affected most by the presence of obese-rat serum (40 times more antimycotic agent was required in the presence of obese-rat serum than in the presence of lean-rat serum). Similar trends were observed for MLCs. These differences in antibiotic activity in the presence of obese-rat serum could be duplicated by the addition of cholesterol but not glucose or insulin to either medium alone or medium with 50% lean-rat serum.
Current guidelines stipulate that testing of antibiotic activity in the presence of serum be done with normal serum (15, 16) . There are no published data defining the effect elevated levels of serum components have on the activity of antibiotics. Several investigators have attributed altered pharmacokinetics in obese individuals to the altered distribution of the agents into extravascular spaces and differences in the rate of clearance (1, 2, 4, 5, 19) . However, the antibiotic-microbe interaction in the presence of altered levels of serum components had not previously been examined.
Metabolic abnormalities which result in changes in the composition of serum are common in Western society. These disorders, which include obesity-associated type II diabetes, hypercholesterolemia, hypertriglyceridemia, and hyperlipidemia, are not mutually exclusive and can be found in a variety of combinations which could act to exacerbate the problems encountered in the evaluation and administration of appropriate drug therapy to individuals with metabolic abnormalities, morbid obesity, or both. Our finding that antibiotic activity can be altered in the presence of serum from genetically obese animals or in media or serum supplemented with cholesterol is hardly surprising. The effect of serum proteins on P-lactam activity and the competitive inhibition of amphotericin B binding by cholesterol have been well documented (1, 2, 6) .
We show herein that the activity of chemotherapeutic agents can be altered by the presence of serum components in concentrations found physiologically in obese (falfa) Zucker rats. Although these rats are hyperglycemic and hyperinsulinemic, the presence of elevated levels of glucose, insulin, or both in medium alone or medium with lean-rat serum did not significantly affect the MIC or MLC of any of the antibiotics tested. In contrast, changes in antibiotic activity which were observed in the presence of obese-rat serum could be duplicated by the addition of cholesterol to medium with or without lean-rat serum. The effect of cholesterol was both antibiotic and microbe dependent. The mechanism by which the antibiotic activity is altered for each antibiotic and organism tested has not yet been determined.
These findings raise some fundamental questions concerning the way in which antibiotic activity is determined. Additional testing is needed in order to evaluate the clinical implications of these findings and determine whether changes in the current methods are in order.
